Tweak in biodiversity norms to boost ayurvedic medicine

India is overhauling regulations under the Biological Diversity Act, 2002, to give its ayurvedic medicine, pharmaceutical and wellness sectors a major boost, and making it easier for companies to access natural resources while safeguarding the country's rich biodiversity.

- Priyanka Sharma

The reforms simplify approval processes, waive access and benefit sharing fees for startups and small businesses with turnover below ₹5 crore, and drastically cut the time required for research, applications and product clearances.

Companies seeking to access biological resources and traditional knowledge typically need to navigate a complex and time-consuming approval process.

By easing compliance, the government aims to accelerate innovation in ayurveda and herbal sciences, expand affordable healthcare options, and strengthen a bio-economy that balances growth with conservation.

For the common public, these reforms hold considerable importance. Many everyday medicines and wellness products, particularly those deeply rooted in traditional Indian systems like ayurveda, are derived from plants and other natural sources. By simplifying regulations, the government aims to accelerate the development and availability of these products, potentially leading to a wider range of accessible and affordable health solutions.